U2AF1 mutations were often mutually exclusive with TET2(OR=0.174, 95% CI 0.038–0.791, Q=0.024), and were common in younger(<60 years)patients with myelodysplastic CMML(MD-CMML). Here, TET2 is linked to chronic myelomonocytic leukemia.